Inhibition of in vitro lymphocyte transformation during chemotherapy in man.
D000743:Anemia, Hemolytic / Q000188:drug therapy; D046508:Culture Techniques; D003520:Cyclophosphamide / Q000627:therapeutic use; D003561:Cytarabine / Q000627:therapeutic use; D006801:Humans; D007108:Immune Tolerance; D037102:Lectins / Q000494:pharmacology*; D007938:Leukemia / Q000188:drug therapy*; D008214:Lymphocytes / Q000187:drug effects*; D015122:Mercaptopurine / Q000627:therapeutic use*; D008727:Methotrexate / Q000627:therapeutic use*; D009369:Neoplasms / Q000188:drug therapy; D011239:Prednisolone / Q000627:therapeutic use*; D012900:Smallpox Vaccine / Q000494:pharmacology*; D014605:Uveitis / Q000188:drug therapy; D014750:Vincristine / Q000627:therapeutic use
D037102:Lectins; D012900:Smallpox Vaccine; D003561:Cytarabine; D014750:Vincristine; D003520:Cyclophosphamide; D011239:Prednisolone; D015122:Mercaptopurine; D008727:Methotrexate